+---------- Auto generated report based on data retrieved from the caAERS database. ----------+


+---------- INPUT QUERY. ----------+
Get all Particpant whose subname (first name or last name) is 'Jack'


+------------Objects Involed . -------+
Participant , Study, StudySite, StudyParticipantAssignment, ExpeditedAdverseEventReport , AdverseEventResponseDescription, Physician, ContactMechanism, Reporter, 
DiseaseHistory, CtepStudyDisease, DiseaseTerm, AnatomicSite, ParticipantHistory, RadiationIntervention, SurgeryIntervention, MedicalDevice, ConcomitantMedication
AdverseEvent, ConcomitantMedicationAttribution, OtherCauseAttribution, CourseAgentAttribution, CourseAgent, Dose, StudyAgent, DiseaseAttribution, DiseaseHistory
SurgeryAttribution, RadiationAttribution, DeviceAttribution, AdverseEventCtcTerm, Lab, SAEReportPriorTherapy, TreatmentInformation, AdverseEventCourse, CourseAgent, SAEReportPreExistingCondition


--- Retrieving  and looping thru Participants ---
--- Total number of Participants # 2


--- Participant # 1 Details---
Name: Jack Randolph
Gender: Male
Race: White
Ethnicity: Hispanic or Latino
D.O.B: Mon Sep 28 00:00:00 EDT 1970


--- Retrieving the Study details for the selected participant. ---
--- Participant has 1 Studies. ---

--- Looping thru Studies . ---
--- Study # 1 Details . ---
Study Short Title: BAY 43-9006
Study Long Title: A Phase 2 Study of BAY 43-9006 for Patients with Imatinib-Resistant Malignant Gastrointestinal Stromal Tumor
Study Phase code: Phase II Trial
Study Status: Active - Trial is open to accrual
Study Terminology Version: CTCAE v3.0
Primary Sponsor: Cancer Therapy Evaluation Program


--- Retrieving the Expedited Adverse Event Report details for the selected participant. ---
--- Participant has 1 Expedited Reports. ---

<?xml version="1.0" encoding="UTF-8"?>
<AdverseEventReport>
  <id>1</id>
  <createdAt xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">2008-02-19 23:22:23.775</createdAt>
  <status xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">PENDING</status>
  <AdverseEventResponseDescription>
    <eventDescription>event description  test</eventDescription>
    <presentStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">INTERVENTION_CONTINUES</presentStatus>
    <retreated>false</retreated>
    <blindBroken>true</blindBroken>
  </AdverseEventResponseDescription>
  <Physician>
    <firstName>karthik</firstName>
    <lastName>iyer</lastName>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">phone</key>
      <value xsi:type="java:java.lang.String">(507)343-7839</value>
    </ContactMechanism>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">fax</key>
      <value xsi:type="java:java.lang.String">1234567890</value>
    </ContactMechanism>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">e-mail</key>
      <value xsi:type="java:java.lang.String">ase@rag.com</value>
    </ContactMechanism>
  </Physician>
  <Reporter>
    <firstName>karthik</firstName>
    <lastName>iyer</lastName>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">phone</key>
      <value xsi:type="java:java.lang.String">(507)343-7839</value>
    </ContactMechanism>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">fax</key>
      <value xsi:type="java:java.lang.String">1234567890</value>
    </ContactMechanism>
    <ContactMechanism xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:org.exolab.castor.mapping.MapItem">
      <key xsi:type="java:java.lang.String">e-mail</key>
      <value xsi:type="java:java.lang.String">ase@rag.com</value>
    </ContactMechanism>
  </Reporter>
  <DiseaseHistory>
    <diagnosisDate>2008-02-05T00:00:00.000-05:00</diagnosisDate>
    <CtepStudyDisease>
      <id>1</id>
      <leadDisease>true</leadDisease>
      <DiseaseTerm>
        <id>231</id>
        <term>Gastrointestinal stromal tumor</term>
        <ctepTerm>Gastrointestinal stromal tumor</ctepTerm>
        <DiseaseCategory>
          <id>122</id>
          <name>Non-Rhabdomyosarcoma Soft Tissue Sarcoma</name>
        </DiseaseCategory>
      </DiseaseTerm>
    </CtepStudyDisease>
    <AnatomicSite>
      <id>8</id>
      <name>Skin</name>
      <category>Dermatology</category>
    </AnatomicSite>
  </DiseaseHistory>
  <ParticipantHistory>
    <height>
      <quantity>100</quantity>
      <unit>Centimeter</unit>
    </height>
    <weight>
      <quantity>100</quantity>
      <unit>Kilogram</unit>
    </weight>
    <baselinePerformanceStatus>0 = Normal Activity, asymptomatic</baselinePerformanceStatus>
  </ParticipantHistory>
  <StudyParticipantAssignment>
    <dateOfEnrollment>2008-02-18T00:00:00.000-05:00</dateOfEnrollment>
    <StudySite>
      <Study>
        <id>1</id>
        <multiInstitutionIndicator>false</multiInstitutionIndicator>
        <shortTitle>BAY 43-9006</shortTitle>
        <longTitle>A Phase 2 Study of BAY 43-9006 for Patients with Imatinib-Resistant Malignant Gastrointestinal Stromal Tumor</longTitle>
        <phaseCode>Phase II Trial</phaseCode>
        <primarySponsorCode>CTEP</primarySponsorCode>
        <status>Active - Trial is open to accrual</status>
        <Ctc>
          <id>3</id>
          <name>CTCAE v3.0</name>
        </Ctc>
        <Identifier>
          <type>Protocol Authority Identifier</type>
          <value>7028</value>
          <primaryIndicator>true</primaryIndicator>
        </Identifier>
        <Identifier>
          <type>Coordinating Center Identifier</type>
          <value>7028</value>
          <primaryIndicator>false</primaryIndicator>
        </Identifier>
      </Study>
      <Organization>
        <id>104522</id>
        <name>Mayo Clinic Rochester</name>
        <nciInstituteCode>MN026</nciInstituteCode>
      </Organization>
    </StudySite>
    <Participant>
      <firstName>Jack</firstName>
      <middleName>K</middleName>
      <lastName>Randolph</lastName>
      <dateOfBirth>
        <day>28</day>
        <month>8</month>
        <year>1970</year>
      </dateOfBirth>
      <gender>Male</gender>
      <race>White</race>
      <ethnicity>Hispanic or Latino</ethnicity>
      <Identifier>
        <type>MRN</type>
        <value>001</value>
        <primaryIndicator>true</primaryIndicator>
      </Identifier>
    </Participant>
  </StudyParticipantAssignment>
  <RadiationIntervention>
    <id>1</id>
    <dosage>10</dosage>
    <dosageUnit>mCi</dosageUnit>
    <lastTreatmentDate>2008-02-05T00:00:00.000-05:00</lastTreatmentDate>
    <adjustment>Continue Radiation as planned</adjustment>
    <administration xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">BT_LDR</administration>
  </RadiationIntervention>
  <SurgeryIntervention>
    <id>1</id>
    <interventionDate>2008-02-06T00:00:00.000-05:00</interventionDate>
    <InterventionSite>
      <name>Artery NOS</name>
    </InterventionSite>
  </SurgeryIntervention>
  <MedicalDevice>
    <id>1</id>
    <brandName>Pfizer</brandName>
    <commonName>Pfizer</commonName>
    <deviceType>bottle</deviceType>
    <manufacturerName>test</manufacturerName>
    <manufacturerCity>colorado</manufacturerCity>
    <modelNumber>001989</modelNumber>
    <lotNumber>980</lotNumber>
    <catalogNumber>iuh7</catalogNumber>
    <expirationDate>2008-02-14T00:00:00.000-05:00</expirationDate>
    <serialNumber>bgf6y</serialNumber>
    <otherNumber>89hgt</otherNumber>
    <implantedDate>2008-02-04T00:00:00.000-05:00</implantedDate>
    <explantedDate>2008-02-05T00:00:00.000-05:00</explantedDate>
    <reprocessorName>any name</reprocessorName>
    <reprocessorAddress>ny city</reprocessorAddress>
    <returnedDate>2008-02-05T00:00:00.000-05:00</returnedDate>
    <DeviceOperator xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">HEALTH_PROFESSIONAL</DeviceOperator>
    <DeviceReprocessed xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</DeviceReprocessed>
    <EvaluationAvailability xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</EvaluationAvailability>
  </MedicalDevice>
  <ConcomitantMedication>
    <name>test conmed</name>
  </ConcomitantMedication>
  <AdverseEvent>
    <gridId>PRY93789b4f-4585-448f-b52a-f74ec972407b</gridId>
    <startDate>2008-02-07T00:00:00.000-05:00</startDate>
    <endDate>2008-02-12T00:00:00.000-05:00</endDate>
    <expected>false</expected>
    <ConcomitantMedicationAttribution>
      <id>5</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <ConcomitantMedication>
        <name>test conmed</name>
      </ConcomitantMedication>
    </ConcomitantMedicationAttribution>
    <OtherCauseAttribution>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <OtherCause>
        <text>test cause</text>
      </OtherCause>
    </OtherCauseAttribution>
    <CourseAgentAttribution>
      <id>4</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <CourseAgent>
        <id>1</id>
        <lastAdministeredDate>2008-02-07T00:00:00.000-05:00</lastAdministeredDate>
        <administrationDelayAmount>12</administrationDelayAmount>
        <administrationDelayUnits xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">MINUTES</administrationDelayUnits>
        <Dose>
          <amount>2</amount>
          <units>Hz</units>
        </Dose>
        <ModifiedDose>
          <amount>11</amount>
          <units>Hz</units>
        </ModifiedDose>
        <StudyAgent>
          <Agent>
            <id>177</id>
            <name>BAY 43-9006 tosylate (BAY 54-9085; sorafenib tosylate)</name>
            <nscNumber>724772</nscNumber>
          </Agent>
        </StudyAgent>
      </CourseAgent>
    </CourseAgentAttribution>
    <DiseaseAttribution>
      <id>7</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <DiseaseHistory>
        <id>1</id>
        <diagnosisDate>2008-02-05T00:00:00.000-05:00</diagnosisDate>
        <CtepStudyDisease>
          <id>1</id>
          <leadDisease>true</leadDisease>
          <DiseaseTerm>
            <id>231</id>
            <term>Gastrointestinal stromal tumor</term>
            <ctepTerm>Gastrointestinal stromal tumor</ctepTerm>
            <DiseaseCategory>
              <id>122</id>
              <name>Non-Rhabdomyosarcoma Soft Tissue Sarcoma</name>
            </DiseaseCategory>
          </DiseaseTerm>
        </CtepStudyDisease>
        <AnatomicSite>
          <id>8</id>
          <name>Skin</name>
          <category>Dermatology</category>
        </AnatomicSite>
      </DiseaseHistory>
    </DiseaseAttribution>
    <SurgeryAttribution>
      <id>3</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <SurgeryIntervention>
        <id>1</id>
        <interventionDate>2008-02-06T00:00:00.000-05:00</interventionDate>
        <InterventionSite>
          <name>Artery NOS</name>
        </InterventionSite>
      </SurgeryIntervention>
    </SurgeryAttribution>
    <RadiationAttribution>
      <id>1</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <RadiationIntervention>
        <id>1</id>
        <dosage>10</dosage>
        <dosageUnit>mCi</dosageUnit>
        <lastTreatmentDate>2008-02-05T00:00:00.000-05:00</lastTreatmentDate>
        <adjustment>Continue Radiation as planned</adjustment>
        <administration xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">BT_LDR</administration>
      </RadiationIntervention>
    </RadiationAttribution>
    <DeviceAttribution>
      <id>2</id>
      <attribution xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Unrelated</attribution>
      <MedicalDevice>
        <id>1</id>
        <brandName>Pfizer</brandName>
        <commonName>Pfizer</commonName>
        <deviceType>bottle</deviceType>
        <manufacturerName>test</manufacturerName>
        <manufacturerCity>colorado</manufacturerCity>
        <modelNumber>001989</modelNumber>
        <lotNumber>980</lotNumber>
        <catalogNumber>iuh7</catalogNumber>
        <expirationDate>2008-02-14T00:00:00.000-05:00</expirationDate>
        <serialNumber>bgf6y</serialNumber>
        <otherNumber>89hgt</otherNumber>
        <implantedDate>2008-02-04T00:00:00.000-05:00</implantedDate>
        <explantedDate>2008-02-05T00:00:00.000-05:00</explantedDate>
        <reprocessorName>any name</reprocessorName>
        <reprocessorAddress>ny city</reprocessorAddress>
        <returnedDate>2008-02-05T00:00:00.000-05:00</returnedDate>
        <DeviceOperator xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">HEALTH_PROFESSIONAL</DeviceOperator>
        <DeviceReprocessed xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</DeviceReprocessed>
        <EvaluationAvailability xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">YES</EvaluationAvailability>
      </MedicalDevice>
    </DeviceAttribution>
    <AdverseEventCtcTerm>
      <ctc-term>
        <id>3002</id>
        <term>Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)</term>
        <ctepTerm>Allergic rhinitis</ctepTerm>
        <ctepCode>10001723</ctepCode>
        <otherRequired>false</otherRequired>
        <CtcCategory>
          <id>301</id>
          <name>ALLERGY/IMMUNOLOGY</name>
        </CtcCategory>
      </ctc-term>
      <universal-term>Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)</universal-term>
      <term xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="CtcTerm">
        <id>3002</id>
        <term>Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)</term>
        <ctepTerm>Allergic rhinitis</ctepTerm>
        <ctepCode>10001723</ctepCode>
        <otherRequired>false</otherRequired>
        <CtcCategory>
          <id>301</id>
          <name>ALLERGY/IMMUNOLOGY</name>
        </CtcCategory>
      </term>
    </AdverseEventCtcTerm>
    <AdverseEventMeddraLowLevelTerm />
    <grade xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Mild</grade>
    <hospitalization xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">1: Hospitalization</hospitalization>
  </AdverseEvent>
  <Lab>
    <id>1</id>
    <labTerm>
      <term>Blood neutrophils (ANC)</term>
      <category>
        <name>Hematologic</name>
      </category>
    </labTerm>
    <units>mm3</units>
    <baseline>
      <value>2</value>
      <date>2008-01-01T00:00:00.000-05:00</date>
    </baseline>
    <nadir>
      <value>4</value>
      <date>2008-01-11T00:00:00.000-05:00</date>
    </nadir>
    <recovery>
      <value>3</value>
      <date>2008-02-08T00:00:00.000-05:00</date>
    </recovery>
  </Lab>
  <SAEReportPriorTherapy>
    <id>1</id>
    <PriorTherapy>
      <id>17</id>
      <text>Surgery</text>
      <meddraTerm>10042609</meddraTerm>
      <meddraCode>Surgery</meddraCode>
    </PriorTherapy>
    <other>test comments</other>
    <startDate>2008-02-04T00:00:00.000-05:00</startDate>
  </SAEReportPriorTherapy>
  <Summary id="Participant">
    <value>Jack Randolph (001)</value>
  </Summary>
  <Summary id="Study">
    <value>A Phase 2 Study of BAY 43-9006 for Patients with Imatinib-Resistant Malignant Gastrointestinal Stromal Tumor (7028)</value>
  </Summary>
  <Summary id="Report created at">
    <value>2008-02-19 23:22:23.775</value>
  </Summary>
  <Summary id="Primary AE">
    <value>Allergic rhinitis (including sneezing, nasal stuffiness, postnasal drip)</value>
  </Summary>
  <Summary id="AE count">
    <value>1</value>
  </Summary>
  <Summary id="Public identifier">
    <value>MN026-MN026</value>
  </Summary>
  <Summary id="Ticket number" />
  <Summary id="Next report due" />
  <TreatmentInformation>
    <firstCourseDate>2008-02-05T00:00:00.000-05:00</firstCourseDate>
    <TreatmentAssignment>
      <code>TAC1</code>
      <description>(Cycle=28 days)
BAY 43-9006: 400mg PO BID</description>
    </TreatmentAssignment>
    <totalCourses>12</totalCourses>
    <AdverseEventCourse>
      <number>2</number>
      <date>2008-02-06T00:00:00.000-05:00</date>
    </AdverseEventCourse>
    <CourseAgent>
      <id>1</id>
      <lastAdministeredDate>2008-02-07T00:00:00.000-05:00</lastAdministeredDate>
      <administrationDelayAmount>12</administrationDelayAmount>
      <administrationDelayUnits xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:type="java:java.lang.String">MINUTES</administrationDelayUnits>
      <Dose>
        <amount>2</amount>
        <units>Hz</units>
      </Dose>
      <ModifiedDose>
        <amount>11</amount>
        <units>Hz</units>
      </ModifiedDose>
      <StudyAgent>
        <Agent>
          <id>177</id>
          <name>BAY 43-9006 tosylate (BAY 54-9085; sorafenib tosylate)</name>
          <nscNumber>724772</nscNumber>
        </Agent>
      </StudyAgent>
    </CourseAgent>
  </TreatmentInformation>
  <SAEReportPreExistingCondition>
    <id>1</id>
    <PreExistingCondition>
      <id>6</id>
      <text>Bronchospasm</text>
    </PreExistingCondition>
  </SAEReportPreExistingCondition>
  <SAEReportPreExistingCondition>
    <id>2</id>
    <PreExistingCondition>
      <id>17</id>
      <text>Fungal infection</text>
    </PreExistingCondition>
  </SAEReportPreExistingCondition>
  <OtherCause>
    <text>test cause</text>
  </OtherCause>
  <AdditionalInformation>
    <id>1</id>
    <autopsyReport>false</autopsyReport>
    <consults>false</consults>
    <dischargeSummary>false</dischargeSummary>
    <flowCharts>false</flowCharts>
    <labReports>false</labReports>
    <obaForm>false</obaForm>
    <other>false</other>
    <pathologyReport>false</pathologyReport>
    <progressNotes>false</progressNotes>
    <radiologyReports>false</radiologyReports>
    <referralLetters>false</referralLetters>
    <irbReport>false</irbReport>
  </AdditionalInformation>
</AdverseEventReport>




--- Participant # 2 Details---
Name: Nicolson Jack
Gender: Male
Race: Asian
Ethnicity: Not Reported
D.O.B: Sun Mar 31 00:00:00 EST 1946


--- Retrieving the Study details for the selected participant. ---
--- Participant has 1 Studies. ---

--- Looping thru Studies . ---
--- Study # 1 Details . ---
Study Short Title: RTOG-0330
Study Long Title: A Pilot Phase II Study of Pre-Operative Radiation Therapy and Thalidomide (IND 48832; NSC 66847) for Low Grade Primary Soft Tissue
Sarcoma or Pre-Operative MAID/Thalidomide/Radiation Therapy for High/Intermediate Grade Primary Soft Tissue Sarcoma of the Extremity
Study Phase code: Phase II Trial
Study Status: Active - Trial is open to accrual
Study Terminology Version: CTCAE v3.0
Primary Sponsor: Cancer Therapy Evaluation Program


--- Retrieving the Expedited Adverse Event Report details for the selected participant. ---
--- Participant has 0 Expedited Reports. ---

